Answers are grounded in this paper and cite their sources.
The lipopentapeptide S-[2,3-bis(palmitoyloxy)-[2-R,S]-propyl]-N-palmitoyl-[R]-cysteinyl-[ R|- α-methylseryI-[R]-α-methylseryl-[S]-asparaginyl-[S]-alanine (Pam3Cys-α-MeSer-α-MeSer-Asn -Ala) has been synthesized as an analogue of the immunoadjuv- ant Pam3Cys-Ser-Ser-Asn -Ala (TPP) via fragment condensations. The two [R]-α-methylserine residues were introduced instead of [L]-serine in order to obtain a mitogenic lipopeptide resistant against proteases. As the parent lipopeptide TPP the analytically pure analogue with McSer was found to induce enhanced cell proliferation of spleen lymphocytes.
No takes yet. Share an insight, caveat, or question.
Metzger et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: